Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine vs Bupropion for Suicidal Depression
NCT00429169Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2004
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine, bupropion in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Jun 2004; status: terminated.
02
Drugs
paroxetinebupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00429169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429169.